CVS suspends sales of Zantac due to possible link to cancer
WOONSOCKET, RI - CVS customers will no longer find Zantac on store shelves, at least for the time being.
CVS has announced their decision to suspend the selling of the popular heartburn medication while it's being investigated for a possible link to cancer.
On September 13, the US Food and Drug Administration (FDA) informed the public of their decision to review the presence of N-nitrosodimethylamine (NDMA) in medicines containing the drug ranitidine.
Ranitidine products, such as Zantac, are used to reduce the production of stomach acid in patients with conditions like heartburn and stomach ulcers.
Health authorities say there is no immediate risk, but advise patients to consult a doctor who can prescribe alternatives to ranitidine.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
LSU QB Myles Brennan suffered 'severe' injury to his left arm; unclear...
Angelo Izzard leading Southern Lab by example
Full interview with Brent Zwerneman of the Houston Chronicle on Texas &...
Sports2-a-Days Preview: Dutchtown Griffins
Southeastern unveils three new logos in latest rebranding effort